JCI insight MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers H. Atakan Ekiz, Thomas B. Huffaker, Allie H. Grossmann, W. Zac Stephens, Matthew A. Williams, June L. Round, and Ryan M. O’Connell First published February 5, 2019 Journal of Biological Cancer WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates […]
Archive | Melanoma News
Smokers May Fare Worse Against the Deadliest Skin Cancer
Source: Health Day, March 2019 MONDAY, Feb. 25, 2019 (HealthDay News) — Melanoma patients who are recent and current smokers have lower survival rates than nonsmokers, suggesting that smoking may weaken immune response to the most deadly skin cancer, researchers say. In a study of more than 700 melanoma patients in the United Kingdom, smokers […]
Posted in Melanoma News, Patients, Latest News
DRUG COMPOUND STOPS HARD-TO-TREAT MELANOMA
Source: Futurity, March 2019 Scientists have figured out a way to stop the progression of a particularly voracious type of melanoma, according to a new study. Damaging effects of ultraviolet light—from sources like sunlight and tanning beds—commonly cause melanoma on the DNA of skin cells. This UV damage can activate genes that encourage precancerous cells […]
Posted in Melanoma News, Health Professionals, Of Interest
A single dose of a PD-1 inhibitor before surgery predicts outcomes in melanoma patients
Source: Medical Express, March 2019 A single dose of a PD-1 inhibitor before surgery for melanoma can put patients in remission. Researchers from the Abramson Cancer Center at the University of Pennsylvania, who documented this finding in the largest cohort of patients to be treated with anti-PD-1 drugs before surgery, also showed that immune responses […]
Posted in Melanoma News, Health Professionals, Clinical Trials
